Health Economic Modelling for MedTech Innovation - What, Why and How

Pharma Market Access Insights - from Mtech Access

Are you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could support your market access journey?

In this episode, converted from a recent live webinar, Calum Jones (Consultant Health Economist) and Nick Swart (Senior Health Economist) discuss what, why and how health economic models can support MedTech innovations to demonstrate value, achieve market access and reach more patients.
Health economic modelling is becoming a key component of the MedTech market access journey. There is increasing need in many countries to demonstrate economic evidence for new technologies, with many health technology assessment (HTA) bodies now requiring economic models before offering guidance for reimbursement, such as NICE’s Medical Technology Evaluation Programme (MTEP). MedTech firms are also recognising that a cost effectiveness model can also offer robust evidence of interventional value to support discussions with payers and other healthcare stakeholders.
In this episode, Calum and Nick share their complementary perspectives and experiences of helping MedTech companies achieve market access.
Please email [e-mail] for a copy of Calum and Nick's slides or to find out more about how Mtech Access can support your market access journey.
Learn more about our Health Economics services here: https://mtechaccess.co.uk/health-economics/
Learn more about our work with Medtech companies here: https://mtechaccess.co.uk/medtech-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Hoofdstukken

1. Health Economic Modelling for MedTech Innovation - What, Why and How (00:00:00)

2. Health economics and MedTech: a natural relationship (00:05:00)

3. Existing opportunities and requirements for Medtech in pursuing market uptake (00:10:55)

4. Review of economic models available to MedTech as tools for pursuing market uptake (budget impact model, cost consequence model, cost effectiveness model) (00:28:15)

5. How health economists conceptualise an economic model for a new asset (00:39:35)

6. Illustrative examples of how models are co-conceptualised with MedTech Partners (00:44:58)